Prekallikrein: Difference between revisions
m Removed 'a(n)' from the beginning of the short description per WP:SDFORMAT, from a request at Wikipedia:Reward board. (via WP:JWB) |
|||
| (17 intermediate revisions by 16 users not shown) | |||
| Line 1: | Line 1: | ||
{{short description|Serine protease}} |
|||
'''Prekallikrein''' (PK), also known as ''Fletcher factor'', is |
'''Prekallikrein''' (PK), also known as '''Fletcher factor''', is an 85,000 Mr [[serine protease]] that complexes with [[high-molecular-weight kininogen]]. PK is the precursor of plasma [[kallikrein]], which is a serine protease that activates [[kinin-kallikrein system|kinins]]. PK is cleaved to produce kallikrein by activated [[Factor XII]] (Hageman factor).<ref name=Goodnight>{{cite book |first=S.H. |last=Goodnight |first2=W.E. |last2=Hathaway |title=Disorders of Hemostasis & Thrombosis: A Clinical Guide |publisher=McGraw Hill Professional |year=2001 |isbn=978-0071348348 |edition=2nd}}</ref> |
||
==Structure== |
|||
| ⚫ | |||
{{See also|Factor_XI#Structure}} |
|||
Prekallikrein is [[Homology (biology)|homologous]] to [[factor XI]], and similarly consists of four [[PAN domain|apple domain]]s and a fifth, catalytic [[serine protease]] domain. The four apple domains create a disk-like platform around the base of the catalytic domain. |
|||
However, unlike factor XI, prekallikrein does not form dimers. |
|||
Prekallikrein is activated to form [[kallikrein]] by [[factor XII]] cleavage of a bond homologous to the corresponding bond cleaved during factor XI activation.<ref>{{cite journal |vauthors=Hooley E, McEwan PA, Emsley J |title=Molecular modeling of the prekallikrein structure provides insights into high-molecular-weight kininogen binding and zymogen activation |journal=Journal of Thrombosis and Haemostasis |volume=5 |issue=12 |pages=2461–6 |date=Dec 2007 |pmid=17922805 |doi=10.1111/j.1538-7836.2007.02792.x|doi-access=free }}</ref> |
|||
| ⚫ | |||
Hereditary deficiencies in PK are very rare. They can cause a prolonged [[APTT]], which can be corrected by incubation of the patient’s plasma. |
Hereditary deficiencies in PK are very rare. They can cause a prolonged [[APTT]], which can be corrected by incubation of the patient’s plasma. |
||
Deficiencies in PK can also be acquired due to some disease states, such as [[angioedema]], infection, [[Disseminated intravascular coagulation|DIC]], and [[sickle-cell disease]].< |
Deficiencies in PK can also be acquired due to some disease states, such as [[angioedema]], infection, [[Disseminated intravascular coagulation|DIC]], and [[sickle-cell disease]].<ref name=Goodnight /> |
||
Although most cases of prekallikrein deficiency are asymptomatic, a few reports link severe prekallikrein deficiency with thrombotic phenomena and recurrent pregnancy loss. More recently, a case of prekallikrein deficiency was shown to be associated with severe mucosal bleeding.< |
Although most cases of prekallikrein deficiency are asymptomatic, a few reports link severe prekallikrein deficiency with thrombotic phenomena and recurrent pregnancy loss. More recently, a case of prekallikrein deficiency was shown to be associated with severe mucosal bleeding.<ref>{{cite journal |vauthors=Dasanu CA, Alexandrescu DT |title=A case of prekallikrein deficiency resulting in severe recurrent mucosal hemorrhage |journal=Am. J. Med. Sci. |volume=338 |issue=5 |pages=429–30 |date=November 2009 |pmid=19773642 |doi=10.1097/MAJ.0b013e3181b270bb }}</ref> |
||
== Discovery of |
== Discovery of prekallikrein == |
||
PK was initially described by Hathaway et al. in 1965 after encountering a Kentucky family who exhibited strikingly abnormal APTT results, but showed no bleeding symptoms. The family appeared to have a hereditary deficiency in an unknown coagulation factor, dubbed “Fletcher factor” after the family. In 1973 Kirk Wuepper determined that Fletcher factor and prekallikrein were the same.<ref> |
PK was initially described by Hathaway et al. in 1965 after encountering a Kentucky family who exhibited strikingly abnormal APTT results, but showed no bleeding symptoms. The family appeared to have a hereditary deficiency in an unknown coagulation factor, dubbed “Fletcher factor” after the family. In 1973 Kirk Wuepper determined that Fletcher factor and prekallikrein were the same.<ref>{{OMIM|229000|KALLIKREIN B, PLASMA, 1; KLKB1}}</ref> |
||
==References== |
==References== |
||
{{Reflist}} |
|||
{{Reflist}} 3. Dasanu CA, et al. "A Case of Prekallikrein Deficiency Resulting in Severe Recurrent Mucosal Hemorrhage". ''American Journal of Medical Sciences'', 2009. |
|||
{{Coagulation}} |
{{Coagulation}} |
||
[[Category:Coagulation system]] |
[[Category:Coagulation system]] |
||
[[Category: |
[[Category:Kinin–kallikrein system]] |
||
Latest revision as of 21:28, 1 July 2021
Prekallikrein (PK), also known as Fletcher factor, is an 85,000 Mr serine protease that complexes with high-molecular-weight kininogen. PK is the precursor of plasma kallikrein, which is a serine protease that activates kinins. PK is cleaved to produce kallikrein by activated Factor XII (Hageman factor).[1]
Structure
[edit]Prekallikrein is homologous to factor XI, and similarly consists of four apple domains and a fifth, catalytic serine protease domain. The four apple domains create a disk-like platform around the base of the catalytic domain. However, unlike factor XI, prekallikrein does not form dimers.
Prekallikrein is activated to form kallikrein by factor XII cleavage of a bond homologous to the corresponding bond cleaved during factor XI activation.[2]
Prekallikrein deficiency
[edit]Hereditary deficiencies in PK are very rare. They can cause a prolonged APTT, which can be corrected by incubation of the patient’s plasma.
Deficiencies in PK can also be acquired due to some disease states, such as angioedema, infection, DIC, and sickle-cell disease.[1]
Although most cases of prekallikrein deficiency are asymptomatic, a few reports link severe prekallikrein deficiency with thrombotic phenomena and recurrent pregnancy loss. More recently, a case of prekallikrein deficiency was shown to be associated with severe mucosal bleeding.[3]
Discovery of prekallikrein
[edit]PK was initially described by Hathaway et al. in 1965 after encountering a Kentucky family who exhibited strikingly abnormal APTT results, but showed no bleeding symptoms. The family appeared to have a hereditary deficiency in an unknown coagulation factor, dubbed “Fletcher factor” after the family. In 1973 Kirk Wuepper determined that Fletcher factor and prekallikrein were the same.[4]
References
[edit]- ^ a b Goodnight, S.H.; Hathaway, W.E. (2001). Disorders of Hemostasis & Thrombosis: A Clinical Guide (2nd ed.). McGraw Hill Professional. ISBN 978-0071348348.
- ^ Hooley E, McEwan PA, Emsley J (Dec 2007). "Molecular modeling of the prekallikrein structure provides insights into high-molecular-weight kininogen binding and zymogen activation". Journal of Thrombosis and Haemostasis. 5 (12): 2461–6. doi:10.1111/j.1538-7836.2007.02792.x. PMID 17922805.
- ^ Dasanu CA, Alexandrescu DT (November 2009). "A case of prekallikrein deficiency resulting in severe recurrent mucosal hemorrhage". Am. J. Med. Sci. 338 (5): 429–30. doi:10.1097/MAJ.0b013e3181b270bb. PMID 19773642.
- ^ Online Mendelian Inheritance in Man (OMIM): KALLIKREIN B, PLASMA, 1; KLKB1 - 229000